Modular Medical, Inc. (MODD)
USD 0.97
(-6.43%)
USD 0.97
(-6.43%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -17.47 Million USD | -25.87% |
| 2023 | -13.87 Million USD | 25.51% |
| 2022 | -18.63 Million USD | -152.55% |
| 2021 | -7.37 Million USD | -38.66% |
| 2020 | -5.32 Million USD | -109.52% |
| 2019 | -2.53 Million USD | -285.21% |
| 2018 | -659.24 Thousand USD | -518.67% |
| 2017 | -106.55 Thousand USD | -242.81% |
| 2016 | -31.08 Thousand USD | -0.29% |
| 2015 | -30.99 Thousand USD | -35.97% |
| 2014 | -22.79 Thousand USD | -9.64% |
| 2013 | -20.79 Thousand USD | -18.85% |
| 2012 | -17.49 Thousand USD | -90.67% |
| 2011 | -9174.00 USD | -19.64% |
| 2010 | -7668.00 USD | 18.43% |
| 2009 | -9400.00 USD | -39.96% |
| 2008 | -6716.00 USD | -3.61% |
| 2007 | -6482.00 USD | 27.22% |
| 2006 | -8906.00 USD | 37.67% |
| 2005 | -14.28 Thousand USD | -130.21% |
| 2004 | -6207.00 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.73 Million USD | -4.64% |
| 2024 FY | -17.47 Million USD | -25.87% |
| 2024 Q4 | -4.28 Million USD | 18.75% |
| 2024 Q2 | -4.18 Million USD | -11.93% |
| 2024 Q3 | -5.26 Million USD | -25.96% |
| 2023 FY | -13.87 Million USD | 25.51% |
| 2023 Q1 | -3.49 Million USD | 23.51% |
| 2023 Q4 | -3.57 Million USD | -6.34% |
| 2023 Q3 | -3.35 Million USD | 2.65% |
| 2023 Q2 | -3.45 Million USD | 1.4% |
| 2022 FY | -18.63 Million USD | -152.55% |
| 2022 Q1 | -4.83 Million USD | -172.78% |
| 2022 Q2 | -4.38 Million USD | 9.38% |
| 2022 Q3 | -4.84 Million USD | -10.49% |
| 2022 Q4 | -4.57 Million USD | 5.51% |
| 2021 Q2 | -1.86 Million USD | 0.72% |
| 2021 Q4 | -1.77 Million USD | 5.24% |
| 2021 Q1 | -1.87 Million USD | 2.27% |
| 2021 Q3 | -1.87 Million USD | -0.53% |
| 2021 FY | -7.37 Million USD | -38.66% |
| 2020 FY | -5.32 Million USD | -109.52% |
| 2020 Q1 | -1.12 Million USD | -11.44% |
| 2020 Q2 | -1.14 Million USD | -2.26% |
| 2020 Q3 | -1.13 Million USD | 1.22% |
| 2020 Q4 | -1.91 Million USD | -69.17% |
| 2019 FY | -2.53 Million USD | -285.21% |
| 2019 Q1 | -249.56 Thousand USD | -37.59% |
| 2019 Q2 | -543.77 Thousand USD | -117.89% |
| 2019 Q3 | -739.2 Thousand USD | -35.94% |
| 2019 Q4 | -1 Million USD | -36.22% |
| 2018 FY | -659.24 Thousand USD | -518.67% |
| 2018 Q3 | -258.77 Thousand USD | -47.03% |
| 2018 Q2 | -176 Thousand USD | -119.62% |
| 2018 Q1 | -80.13 Thousand USD | -967.81% |
| 2018 Q4 | -181.38 Thousand USD | 29.91% |
| 2017 Q1 | -6478.00 USD | 3.56% |
| 2017 FY | -106.55 Thousand USD | -242.81% |
| 2017 Q4 | -7505.00 USD | 2.99% |
| 2017 Q3 | -7736.00 USD | 30.8% |
| 2017 Q2 | -11.17 Thousand USD | -72.57% |
| 2016 Q4 | -6717.00 USD | 2.04% |
| 2016 Q2 | -11.03 Thousand USD | -44.28% |
| 2016 Q1 | -7646.00 USD | 3.91% |
| 2016 Q3 | -6857.00 USD | 37.84% |
| 2016 FY | -31.08 Thousand USD | -0.29% |
| 2015 Q1 | -4925.00 USD | 5.32% |
| 2015 FY | -30.99 Thousand USD | -35.97% |
| 2015 Q2 | -7858.00 USD | -59.55% |
| 2015 Q4 | -7957.00 USD | -5.63% |
| 2015 Q3 | -7533.00 USD | 4.14% |
| 2014 Q3 | -5457.00 USD | 24.31% |
| 2014 Q1 | -4698.00 USD | -3.12% |
| 2014 Q2 | -7210.00 USD | -53.47% |
| 2014 Q4 | -5202.00 USD | 4.67% |
| 2014 FY | -22.79 Thousand USD | -9.64% |
| 2013 Q2 | -6991.00 USD | -95.55% |
| 2013 FY | -20.79 Thousand USD | -18.85% |
| 2013 Q1 | -3575.00 USD | 9.29% |
| 2013 Q4 | -4556.00 USD | -0.24% |
| 2013 Q3 | -4545.00 USD | 34.99% |
| 2012 Q1 | -2047.00 USD | -20.41% |
| 2012 FY | -17.49 Thousand USD | -90.67% |
| 2012 Q4 | -3941.00 USD | -2.6% |
| 2012 Q3 | -3841.00 USD | 37.39% |
| 2012 Q2 | -6135.00 USD | -199.71% |
| 2011 Q2 | -3917.00 USD | -360.82% |
| 2011 Q1 | -850.00 USD | 50.29% |
| 2011 FY | -9174.00 USD | -19.64% |
| 2011 Q4 | -1700.00 USD | -12.58% |
| 2011 Q3 | -1510.00 USD | 61.45% |
| 2010 Q1 | -575.00 USD | 52.08% |
| 2010 FY | -7668.00 USD | 18.43% |
| 2010 Q4 | -1710.00 USD | -76.11% |
| 2010 Q3 | -971.00 USD | 76.53% |
| 2010 Q2 | -4137.00 USD | -619.48% |
| 2009 Q2 | -6355.00 USD | -531.08% |
| 2009 Q3 | -1270.00 USD | 80.02% |
| 2009 Q4 | -1200.00 USD | 5.51% |
| 2009 FY | -9400.00 USD | -39.96% |
| 2009 Q1 | -1007.00 USD | -17.37% |
| 2008 Q3 | -940.00 USD | 75.97% |
| 2008 FY | -6716.00 USD | -3.61% |
| 2008 Q4 | -858.00 USD | 8.72% |
| 2008 Q2 | -3911.00 USD | -6961.4% |
| 2008 Q1 | 57.00 USD | 104.83% |
| 2007 FY | -6482.00 USD | 27.22% |
| 2007 Q2 | -3567.00 USD | -285.62% |
| 2007 Q3 | -1792.00 USD | 49.76% |
| 2007 Q4 | -1180.00 USD | 34.15% |
| 2007 Q1 | -925.00 USD | 41.05% |
| 2006 Q4 | -1569.00 USD | -10.81% |
| 2006 Q2 | -4996.00 USD | -36.84% |
| 2006 FY | -8906.00 USD | 37.67% |
| 2006 Q1 | -3651.00 USD | -105.57% |
| 2006 Q3 | -1416.00 USD | 71.66% |
| 2005 FY | -14.28 Thousand USD | -130.21% |
| 2005 Q3 | -4544.00 USD | -5.23% |
| 2005 Q2 | -4318.00 USD | 0.0% |
| 2005 Q4 | -1776.00 USD | 60.92% |
| 2004 FY | -6207.00 USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 78.607% |
| Cerus Corporation | -37.48 Million USD | 53.4% |
| OrthoPediatrics Corp. | -20.97 Million USD | 16.706% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -59.466% |
| Talis Biomedical Corporation | -62 Million USD | 71.826% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -28.617% |
| Inogen, Inc. | -102.44 Million USD | 82.948% |
| Spectral AI, Inc. | -20.85 Million USD | 16.227% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 71.255% |
| CVRx, Inc. | -41.19 Million USD | 57.596% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 2828.852% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -97.401% |
| Orthofix Medical Inc. | -151.39 Million USD | 88.461% |
| Venus Concept Inc. | -37.25 Million USD | 53.101% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 71.648% |
| Bioventus Inc. | -156.23 Million USD | 88.818% |
| BrainsWay Ltd. | -4.19 Million USD | -316.25% |
| Envoy Medical, Inc. | -29.9 Million USD | 41.588% |
| electroCore, Inc. | -18.83 Million USD | 7.242% |
| IceCure Medical Ltd | -14.65 Million USD | -19.233% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 66.829% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -27.099% |
| MaxCyte, Inc. | -37.92 Million USD | 53.933% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -47.308% |
| Nexalin Technology, Inc. | -4.64 Million USD | -275.803% |
| PAVmed Inc | -64.17 Million USD | 72.778% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 66.703% |
| RxSight, Inc. | -48.6 Million USD | 64.059% |
| Sight Sciences, Inc. | -55.54 Million USD | 68.549% |
| SI-BONE, Inc. | -43.33 Million USD | 59.687% |
| TELA Bio, Inc. | -46.66 Million USD | 62.562% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 70.409% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 64.726% |
| LivaNova PLC | 17.54 Million USD | 199.567% |
| 908 Devices Inc. | -36.39 Million USD | 52.004% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 90.64% |
| Nemaura Medical Inc. | -14.14 Million USD | -23.518% |
| NeuroPace, Inc. | -32.95 Million USD | 46.99% |
| LENSAR, Inc. | -14.38 Million USD | -21.463% |
| Apyx Medical Corporation | -18.71 Million USD | 6.642% |
| Cutera, Inc. | -162.83 Million USD | 89.271% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -61.311% |
| BioSig Technologies, Inc. | -29.04 Million USD | 39.844% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 78.867% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 20.911% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 125.789% |
| Axonics, Inc. | -6.08 Million USD | -186.958% |
| Outset Medical, Inc. | -172.79 Million USD | 89.89% |
| IRIDEX Corporation | -9.57 Million USD | -82.55% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 83.503% |
| IRadimed Corporation | 17.19 Million USD | 201.612% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -111.912% |
| INVO Bioscience, Inc. | -8.03 Million USD | -117.434% |
| Telesis Bio, Inc. | -47.72 Million USD | 63.394% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 270.556% |
| Varex Imaging Corporation | -47.7 Million USD | 63.375% |
| Quipt Home Medical Corp. | -2.78 Million USD | -527.514% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -54.794% |
| Pulmonx Corporation | -60.84 Million USD | 71.287% |
| Dynatronics Corporation | -2.69 Million USD | -547.584% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -53.421% |
| Semler Scientific, Inc. | 20.58 Million USD | 184.876% |
| InMode Ltd. | 197.91 Million USD | 108.827% |
| Bruker Corporation | 427.2 Million USD | 104.089% |
| Cytosorbents Corporation | -28.5 Million USD | 38.718% |
| DexCom, Inc. | 541.5 Million USD | 103.226% |
| Align Technology, Inc. | 445.05 Million USD | 103.925% |
| Viveve Medical, Inc. | -22.02 Million USD | 20.688% |
| ZimVie Inc. | -393.28 Million USD | 95.558% |
| Movano Inc. | -29.28 Million USD | 40.341% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -43.81% |
| Nexalin Technology, Inc. | -4.64 Million USD | -275.803% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 2828.852% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 92.152% |
| Profound Medical Corp. | -28.56 Million USD | 38.85% |
| Insulet Corporation | 206.3 Million USD | 108.468% |
| enVVeno Medical Corporation | -23.51 Million USD | 25.71% |
| Surmodics, Inc. | -11.54 Million USD | -51.36% |
| iCAD, Inc. | -4.84 Million USD | -260.429% |
| Nuwellis, Inc. | -20.2 Million USD | 13.553% |
| Biotricity, Inc. | -14.09 Million USD | -23.951% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 85.843% |
| Aethlon Medical, Inc. | -12.2 Million USD | -43.101% |
| InspireMD, Inc. | -19.91 Million USD | 12.282% |
| PAVmed Inc. | -64.17 Million USD | 72.778% |
| BIOLASE, Inc. | -20.63 Million USD | 15.326% |
| Beyond Air, Inc. | -60.24 Million USD | 71.0% |
| FONAR Corporation | 10.56 Million USD | 265.32% |
| AxoGen, Inc. | -21.71 Million USD | 19.552% |
| Vivani Medical, Inc. | -25.65 Million USD | 31.896% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 161.266% |
| Inari Medical, Inc. | -1.63 Million USD | -967.848% |
| UFP Technologies, Inc. | 44.92 Million USD | 138.888% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -240.391% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -164.488% |
| Tenon Medical, Inc. | -15.58 Million USD | -12.124% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | -13.25% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 50.556% |
| AdaptHealth Corp. | -678.89 Million USD | 97.427% |
| Sintx Technologies, Inc. | -8.25 Million USD | -111.527% |
| NanoVibronix, Inc. | -3.71 Million USD | -370.763% |
| Quanterix Corporation | -32.33 Million USD | 45.97% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -54.794% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 3702.062% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 94.305% |
| TransMedics Group, Inc. | -25.02 Million USD | 30.198% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 21.068% |
| NeuroMetrix, Inc. | -6.52 Million USD | -167.555% |
| Hyperfine, Inc. | -44.23 Million USD | 60.509% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 77.746% |
| Biomerica, Inc. | -5.97 Million USD | -192.238% |
| Bone Biologics Corporation | -8.94 Million USD | -95.223% |
| AVITA Medical, Inc. | -39.16 Million USD | 55.398% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -75.509% |
| Silk Road Medical, Inc | -55.74 Million USD | 68.66% |